The management of osteoporosis.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Baillière's Clinical Endocrinology and Metabolism

• Publication date

  1997-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0950-351X(97)80505-8PMID 9222486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Benefits, Risks and Costs of Calcium Supplementation in Postmenopausal Women

  2012cited by this paper
• Cost-effectiveness analysis of hormone replacement therapy and lifestyle intervention for hip fracture.

  2010cited by this paper
• Spine fracture risk is predicted by non-spine fractures

  2006cited by this paper
• Testosterone therapy in glucocorticoid-treated men

  2006cited by this paper
• Fracture protection provided by long-term estrogen treatment

  2005cited by this paper
• Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

  1996cited by this paper
• Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

  1996cited by this paper
• Salmon calcitonin in the prevention of bone loss at perimenopause.

  1996cited by this paper
• Androgen supplementation in eugonadal men with osteoporosis-effects of 6 months of treatment on bone mineral density and cardiovascular risk factors.

  1996cited by this paper
• Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

  1996cited by this paper
• Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study.

  1996cited by this paper
• Risk of venous thrombosis with hormone-replacement therapy.

  1996cited by this paper
• Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.

  1996cited by this paper
• Heated oyster shell-seaweed calcium (AAA Ca) on osteoporosis

  1996cited by this paper
• Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post‐menopausal ages

  1996cited by this paper
• Testosterone therapy in glucocorticoid-treated men.

  1996cited by this paper
• Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial.

  1995cited by this paper
• The effects of calcium supplementation (milk powder or tablets) and exercise on bone density in postmenopausal women

  1995cited by this paper
• The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT Trials. Frailty and Injuries: Cooperative Studies of Intervention Techniques.

  1995cited by this paper
• Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

  1995cited by this paper
• The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women.

  1995cited by this paper
• Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group.

  1995cited by this paper
• A comparison of the effectiveness and cost of treatment for vertebral fractures in women.

  1995cited by this paper
• Osteoporosis in men.

  1995cited by this paper
• The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.

  1995cited by this paper
• Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study.

  1995cited by this paper
• Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D.

  1995cited by this paper
• Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.

  1995cited by this paper
• Estrogen and calcium supplement use among Japanese-American women: effects upon bone loss when used singly and in combination.

  1995cited by this paper
• Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial.

  1995cited by this paper
• A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.

  1995cited by this paper
• Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women.

  1995cited by this paper
• Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period.

  1995cited by this paper
• Estrogen Replacement Therapy and Fractures in Older Women

  1995cited by this paper
• Severe Osteoporosis in Men

  1995cited by this paper
• Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement.

  1995cited by this paper
• Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause--a clinical research center study.

  1995cited by this paper
• Two years' effectiveness of intravenous pamidronate (APD) versus oral fluoride for osteoporosis occurring in the postmenopause

  1994cited by this paper
• Calcium Supplementation with and without Hormone Replacement Therapy To Prevent Postmenopausal Bone Loss

  1994cited by this paper
• A comparison of the effects of oestrogen/progestogen, high-dose oral calcium, intermittent cyclic etidronate and an ADFR regime on calcium kinetics and bone mass in postmenopausal women with spinal osteoporosis

  1994cited by this paper
• Effects of 1α-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis

  1994cited by this paper
• Alfacalcidol (alpha D3) and calcium in osteoporosis.

  1994cited by this paper
• Long‐term effect of calcium supplementation on bone loss in perimenopausal women

  1994cited by this paper
• Bone histomorphometric changes after cyclic therapy with phosphate and etidronate disodium in women with postmenopausal osteoporosis.

  1994cited by this paper
• Effect of intranasal salmon calcitonin therapy on bone mass and bone turnover in early postmenopausal women: A dose-response study

  1994cited by this paper
• Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients

  1994cited by this paper
• Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis.

  1994cited by this paper
• Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post‐menopausal osteoporosis

  1994cited by this paper
• Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women

  1994cited by this paper
• Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion.

  1994cited by this paper
• A multifactorial intervention to reduce the risk of falling among elderly people living in the community.

  1994cited by this paper
• Postmenopausal estrogen replacement: a long-term cohort study.

  1994cited by this paper
• Symptomatic fracture incidence in elderly men and women: The Dubbo osteoporosis epidemiology study (DOES)

  1994cited by this paper
• Effect of external hip protectors on hip fractures.

  1993cited by this paper
• Risk of hip fracture after osteoporosis fractures. 451 women with fracture of lumbar spine, olecranon, knee or ankle.

  1993cited by this paper
• The effect of postmenopausal estrogen therapy on bone density in elderly women.

  1993cited by this paper
• Maintained bone density at advanced ages after long term treatment with low dose oestradiol implants

  1993cited by this paper
• Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

  1993cited by this paper
• Effect of calcium supplementation on bone loss in postmenopausal women.

  1993cited by this paper
• Increased osteoclast development after estrogen loss: mediation by interleukin-6.

  1992cited by this paper
• Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.

  1992cited by this paper
• Increased osteoclast development after estrogen loss: mediation by interleukin-6

  1992cited by this paper
• Low bone mass in hypogonadal males. Effect of testosterone substitution therapy, a densitometric study.

  1992cited by this paper
• Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome.

  1992cited by this paper
• Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women

  1992cited by this paper
• Annual injection of vitamin D and fractures of aged bones

  1992cited by this paper
• Treatment of postmenopausal osteoporosis with calcitriol or calcium.

  1992cited by this paper
• The effects of calcium supplementation and exercise on bone density in elderly Chinese women

  1992cited by this paper
• Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen

  1992cited by this paper
• A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women

  1991cited by this paper
• Pre-existing fractures and bone mass predict vertebral fracture incidence in women.

  1991cited by this paper
• Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis.

  1990cited by this paper
• Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy.

  1990cited by this paper
• A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women.

  1990cited by this paper
• Studies of osteoporosis in Japan.

  1990cited by this paper
• Screening procedure for women at risk of developing postmenopausal osteoporosis

  1990cited by this paper
• Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study.

  1990cited by this paper
• Calcitriol treatment is not effective in postmenopausal osteoporosis.

  1989cited by this paper
• Prevention of postmenopausal bone loss by tiludronate

  1989cited by this paper
• Calcitriol in the treatment of postmenopausal osteoporosis.

  1988cited by this paper
• Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

  1988cited by this paper
• Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium.

  1987cited by this paper
• Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1 alpha (OH)-vitamin D3.

  1987cited by this paper
• Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study.

  1987cited by this paper
• Prophylaxis against vitamin D deficiency in the elderly by regular sunlight exposure.

  1986cited by this paper
• The acute biochemical effects of four proprietary calcium preparations.

  1986cited by this paper
• Does 1,25(OH)2D3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women.

  1985cited by this paper
• Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1 alpha-OHD3) and 1, 24 Dihydroxycholecalciferol (1, 24(OH)2D3).

  1985cited by this paper
• Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

  1982cited by this paper
• Effect of 1,25‐dihydroxy ‐ vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis

  1981cited by this paper
• Prevention of spinal osteoporosis in oophorectomised women.

  1980cited by this paper
• Treatment of spinal osteoporosis in postmenopausal women.

  1980cited by this paper
• Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females

  1971cited by this paper
• THEORIES OF COLOUR VISION

  1905cited by this paper

• Deciphering the gut microbiome’s metabolic code: pathways to bone health and novel therapeutic avenues

  2025cites this paper
• Fluorescent collagen hybridizing peptide for quantifying collagen denaturation in cortical bone

  2025cites this paper
• Anti-osteoporotic potential of a probiotic mixture containing Limosilactobacillus reuteri and Weissella cibaria in ovariectomized rats

  2025cites this paper
• Post-cardiopulmonary resuscitation trauma: retrospective analysis of skeletal and visceral injuries in autopsy findings

  2025cites this paper
• Relationships among Physical Activity Bone Mineral Density and Body Composition in Obese and Athletes

  2024cites this paper
• Vertebral bone quality score as a new tool for osteoporosis diagnosis in patients undergoing lumbosacral fusion surgery: a single center cohort study

  2024cites this paper
• The association of melatonin use and hip fracture: a matched cohort study

  2023cites this paper
• OPG gene-modified adipose-derived stem cells improve bone formation around implants in osteoporotic rat maxillae

  2023cites this paper
• Bone health, body composition and physical fitness dose–response effects of 16 weeks of recreational team handball for inactive middle‐to‐older‐aged males – A randomised controlled trial

  2023cites this paper
• Diagnosis and Management of Osteosarcopenia

  2023cites this paper
• Association between segmental body composition and bone mineral density in US adults: results from the NHANES (2011–2018)

  2023cites this paper
• Autophagy, SMAD-1, and apoptotic pathways are correlated with L-carnitine protective effect against dexamethasone-induced osteoporosis in Wistar rats

  2022cites this paper
• Does Fracture Liaison Service Improves Fracture Risk Assessment among Patients with Fragility Fractures? A Systematic Review

  2021cites this paper
• ETS Proto-Oncogene 1 Suppresses MicroRNA-128 Transcription to Promote Osteogenic Differentiation Through the HOXA13/β-Catenin Axis

  2021cites this paper
• The Association between Short Inter-Pregnancy Interval and Postmenopausal Osteoporosis, Saudi Arabia, Taif City, 2019: A case-control study

  2021cites this paper
• Perception of Osteoporosis among General Population in Eastern Province, Saudi Arabia

  2021cites this paper
• Study Of Dosha Dushya SammurchanaIn Indralupta And Its Management With Bhallataka And Madhu W.S.R. To Alopecia Areata

  2020cites this paper
• Brachial-ankle pulse wave velocity is associated with the risk of osteoporosis: a cross-sectional evidence from a Chinese community-based cohort

  2020cites this paper
• The Effectiveness of Osteoporosis Screening and Treatment in the Midwest

  2018cites this paper
• Advances in Building BodyInNumbers Exercise and Wellness Health Strategy Framework

  2018cites this paper
• Prevalence of hypovitaminosis D and secondary hyperparathyroidism in postmenopausal women Prevalência de hipovitaminose D e hiperparatireoidismo secundário em mulheres na pós-menopausa

  2018cites this paper
• DIETARY INTERVENTIONS FOR BONE HEALTH IN PEOPLE WITH LEARNING DISSABILITY

  2017cites this paper
• Metabolic bone disease

  2017cites this paper
• Trends Analysis of rhBMP2 Utilization in Single-Level Anterior Lumbar Interbody Fusion in the United States

  2017cites this paper
• Longitudinal Assessment of Bone Mineral Density and Body Composition in Competitive Cyclists

  2017cites this paper
• Relationship between Bone-Specific Physical Activity Scores and Measures for Body Composition and Bone Mineral Density in Healthy Young College Women

  2016cites this paper
• Cost-effectiveness of intravenous 5 mg zoledronic acid to prevent subsequent clinical fractures in postmenopausal women after hip fracture: A model-based analysis

  2016cites this paper
• Dilemmas in the management of osteoporosis

  2015cites this paper
• Serum vitamin D and the metabolic syndrome among osteoporotic postmenopausal female patients of a family practice clinic in Jordan.

  2015cites this paper
• Insufficiency Fracture of the Tibial Plateau: A Disease of Rare Diagnosis

  2015cites this paper
• Bone Tissue Engineering and Bony Scaffolds

  2015cites this paper
• Impact Evaluation of Calcium and Vitamin D Supplementation and Physical Activity on Bone Health Status of Elderly Population of Urban Vadodara

  2015cites this paper
• Risk factors for Osteoporosis in Women Forty Years and Above in Arar City, Kingdom of Saudi Arabia (KSA)

  2015cites this paper
• Biomechanical and microstructural benefits of physical exercise associated with risedronate in bones of ovariectomized rats

  2014cites this paper
• The Chinese skeleton: insights into microstructure that help to explain the epidemiology of fracture

  2014cites this paper
• Osteoporosis – a current view of pharmacological prevention and treatment

  2013cites this paper
• Osteoporosis in Female Athletes

  2013cites this paper
• Osteoporosis Knowledge, Health Beliefs, and Preventive Behavior: A Comparison Between Younger and Older Women Living in a Rural Area

  2013cites this paper
• Efficacy of different medicines used for the treatment of osteoporosis by using dual energy x-ray absorptiometry

  2012cites this paper
• Approach to the Screening and Diagnosis of Osteoporosis

  2012cites this paper
• Variable selection using the optimal ROC curve: An application to a traditional Chinese medicine study on osteoporosis disease

  2012cites this paper
• Are Hospitalized Patients With Fragile Fractures Managed Properly in Relation to Underlying Osteoporosis?

  2012cites this paper
• Bilateral atypical insufficiency fractures of the proximal tibia and a unilateral distal femoral fracture associated with long-term intravenous bisphosphonate therapy: a case report

  2012cites this paper
• Role of Medicinal Plants and Natural Products on Osteoporotic Fracture Healing

  2012cites this paper
• Raman and mechanical properties correlate at whole bone- and tissue-levels in a genetic mouse model.

  2011cites this paper
• From Brittle Bones to Standard Deviations: The Historical Development of Osteoporosis in the Late Twentieth Century

  2011cites this paper
• Assessing osteoporosis risk factors in Spanish menopausal women

  2011cites this paper
• A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene and bone mineral density in Japanese male workers

  2011cites this paper
• Kyphoplasty and vertebroplasty in the management of osteoporosis with subsequent vertebral compression fractures.

  2010cites this paper
• Tratamiento farmacológico de la osteoporosis postmenopáusica

  2010cites this paper
• Inhibidores de bomba de protones y riesgo de osteoporosis

  2009cites this paper
• SETTING THE SITES HIGH: MEASURING VIEWER ATTENTION TO AND RECALL OF FRAMED OSTEOPOROSIS PREVENTION PRINT ADVERTISEMENTS

  2009cites this paper
• ANÁLISE DA PREVALÊNCIA DE OSTEOPOROSE E FRATURAS ATRAUMÁTICAS EM MULHERES IDOSAS DA CIDADE DE

  2009cites this paper
• European guidance for the diagnosis and management of osteoporosis in postmenopausal women

  2008cites this paper
• Vitamin D inadequacy in postmenopausal women in Eastern Asia

  2008cites this paper
• Evolving Issues in the Clinical and Managed Care Settings on the Management of Menopause Following the Women's Health Initiative

  2008cites this paper
• Preventive Care Programs to Improve the Management of Perimenopausal and Postmenopausal Women: Guidance for Managed Care Organizations

  2008cites this paper
• Parkinson's disease and resistive exercise: Rationale, review, and recommendations

  2008cites this paper
• Choline-stabilized orthosilicic acid supplementation as an adjunct to Calcium/Vitamin D3 stimulates markers of bone formation in osteopenic females: a randomized, placebo-controlled trial

  2008cites this paper
• THE INTERRELATIONSHIP BETWEEN OSTEOPOROSIS AND ORAL BONE LOSS

  2007cites this paper
• A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis

  2007cites this paper
• HipWatch: osteoporosis investigation and treatment after a hip fracture: a 6-month randomized controlled trial.

  2007cites this paper
• Picking a bone with contemporary osteoporosis management: nutrient strategies to enhance skeletal integrity.

  2007cites this paper
• One fracture is enough!: Experience with a prospective and consecutive osteoporosis screening program with 239 fracture patients

  2006cites this paper
• Epidemiology, etiology, and diagnosis of osteoporosis.

  2006influential citation
• High-intensity resistance training and postmenopausal bone loss: a meta-analysis

  2006cites this paper
• Effect of trabecular bone loss on cortical strain rate during impact in an in vitro model of avian femur

  2006cites this paper
• Vitamin D supplementation: what is right?

  2006cites this paper
• The role of osteocytes and bone microstructure in preventing osteoporotic fractures

  2006influential citation
• Dynamic short crack growth in cortical bone

  2006influential citation
• Cost-Effectiveness Analysis of Various Screening Methods for Osteoporosis in Perimenopausal Thai Women

  2006cites this paper
• Multinational survey of osteoporotic fracture management

  2005cites this paper
• The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein–induced bone formation

  2005cites this paper
• The history of geriatric medicine and hospital care of the elderly in England between 1929 and the 1970s

  2004cites this paper
• The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.

  2004cites this paper
• The Diagnosis, Prevention and Treatment of Postmenopausal Osteoporosis

  2004cites this paper
• Effects of a triphasic combination oral contraceptive containing norgestimate/ethinyl estradiol on biochemical markers of bone metabolism in young women with osteopenia secondary to hypothalamic amenorrhea.

  2003cites this paper
• The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture

  2003cites this paper
• MANAGEMENT OF OSTEOPOROSIS IN AN ORTHOPAEDIC DEPARTMENT: AUDIT IMPROVES PRACTICE

  2002cites this paper
• Comparison of logistic and Bayesian classifiers for evaluating the risk of femoral neck fracture in osteoporotic patients

  2001cites this paper
• Calcium Supplementation with Calcium-Rich Mineral Waters: A Systematic Review and Meta-analysis of its Bioavailability

  2000cites this paper
• Advanced prostate cancer: an update.

  2000influential citation
• Calcitonin and calcitonin receptors: bone and beyond

  2000cites this paper
• Bone Mineral in Prepubertal Children: Gender and Ethnicity

  2000cites this paper
• Potential of gene therapy for treating osteogenesis imperfecta.

  2000cites this paper
• Is screening for osteoporosis worthwhile?

  1998cites this paper
• Osteoporosis--emerging consensus.

  1997cites this paper
• T cell subtypes in the management of osteoporosis with bisphosphonates and in the autoimmune reaction to collagen in rheumatoid arthritis

  year unknowncites this paper
• Relationship between visceral and subcutaneous fat and bone health in American adults: a cross-sectional study

  year unknowninfluential citation